Despite strong cash reserves and project milestones, the complete drop-off in quarterly revenue and widening losses signal execution risk. Traders should monitor upcoming pilot data and FOAK permitting progress as catalysts, but near-term fundamentals remain weak.
Price Chart
Executive Summary
Aduro Clean Technologies reported Q3 fiscal 2026 results with zero revenue versus $63K in the prior year, a widened operating loss, and higher Adjusted EBITDA burn, despite a strong cash position of $39.4M following a $28.7M public offering. The company highlighted progress in pilot plant operations and FOAK facility development, but financials show deteriorating fundamentals.
Key Financial Metrics
Key Facts
- Q3 2026 revenue was $0 vs $63,399 in Q3 2025, a 100% decline
- YTD revenue increased 7% to $167,206 due to non-recurring customer engagement programs
- Loss from operations narrowed to $1.63M from $2.85M YoY, but YTD loss widened to $14.42M from $8.43M
- Adjusted EBITDA was $(2.77M) in Q3, worse than $(1.84M) in Q3 2025
- Cash balance increased to $39.42M as of February 28, 2026, up from $6.96M in Q4 2025, due to $28.74M net proceeds from a U.S. public offering
- Pilot plant transitioned to operating campaigns; FOAK site selected at Chemelot; LOI signed for offtake and MOU for licensing package
Financial Impact
Revenue collapse and increased losses despite capital raise; cash runway extended but no commercial revenue yet
Risk Factors
- Continued revenue volatility and lack of recurring commercial income
- Pilot-to-commercial scale-up risk for Hydrochemolytic™ technology
- Dilution risk if future capital raises are needed despite current cash position
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274358 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 6-K | $10.13 | awaiting T+60 | — | $9.60 (−5.23%) |
Oct 15, 2026 10d ago | 6-K | $9.95 | awaiting T+60 | — | $9.60 (−3.47%) |
Sep 28, 2026 27d ago | SC 13D/A | $12.25 | awaiting T+60 | — | $9.60 (−21.63%) |
Sep 25, 2026 4w ago | SC 13D/A | $12.31 | awaiting T+60 | — | $9.60 (−22.01%) |
Sep 1, 2026 7w ago | Press Release | $13.34 | awaiting T+60 | — | $9.60 (−28.04%) |
Aug 21, 2026 9w ago | Institutional Cluster | $16.04 | awaiting T+60 | — | $9.60 (−40.15%) |
Jun 25, 2026 17w ago | 6-K | $15.21 $12.61 | ▼ −17.09% | ▼ −23.20% | $9.60 (−36.88%) |
Jun 17, 2026 18w ago | Press Release | $14.72 $12.90 | ▼ −12.36% | ▼ −15.51% | $9.60 (−34.78%) |
Jun 12, 2026 19w ago | 6-K | $14.81 $13.26 | ▲ +10.47% | ▲ +11.47% | $9.60 (+35.18%) |
Jun 10, 2026 19w ago | 6-K | $15.10 $13.58 | ▼ −10.07% | ▼ −14.46% | $9.60 (−36.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers